Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2026-05-22 18:04:42 ET · period of report 2026-05-22 · accession 0001571545-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 18:04 | 2026-05-22 | DBD | Markus Maura A. | Dir | A - Grant | $0.00 | +2,621 | 10.6K | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-22 | A | A | 2,621 | $0.00 | 10,617 | D | — | — | (F1) Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock. (F2) Number includes Restricted Stock Units. (F3) Number includes Deferred Shares. |